With the help of rapidly developing technology in medicine, it has become quite easy to identify many problems that cannot be explained or have difficulty explaining and to find remedies now. One of these conveniences is to determine the health status of pregnancy before pregnancy occurs and to provide the possibility of genetic diagnosis in the embryo. In Turkey in vitro fertilization treatments, it is now possible to examine whether the baby is healthy while it is still a 7 – 8-cell embryo. With this examination, the placement of the embryo with a patient or genetic disability into the uterus or the formation of an unhealthy pregnancy can be prevented from the very beginning.


In order to make a genetic diagnosis in embryos, it is necessary to examine the embryos in a laboratory environment. In order to perform this examination, eggs taken from a woman and sperm cells taken from a man must be combined in a laboratory environment. In short, fertilization and embryo development should be ensured by microinjection method. The genetic diagnosis method in embryos is a very difficult and costly method and requires advanced technology methods. This method is applied only to patients with special risk factors for pregnancy formation. Which couples will be applied genetic diagnosis application in IVF treatment varies according to the purpose of the method.


  • In the study of disease in embryos
  • In the determination of the disease in patients at risk of cancer
  • In the anomaly scan


The real goal in researching diseases in embryos is to increase chances of achieving a healthy pregnancy by selecting and transferring healthy and disease-free embryos in families that can spontaneously conceive naturally, but are carriers of a certain disease and are therefore at risk of having an unhealthy pregnancy.

In the study of genetic diseases, cells in blood samples obtained from people are deciphered and the genetic materials contained in them are collected together. In order for this examination to be successful, DNA is reproduced by specially developed methods in order to obtain enough material to ensure that it can be performed without errors. The gene sequences in the replicated DNA content are identified separately. Changes and disorders that may occur are determined in advance. Thanks to these examinations, diseases are diagnosed and it also helps in identifying people at risk of diseases. With this application, many diseases can be diagnosed.

These diseases can be sorted as follows:

  • Genetic diseases
  • Congenital hearing loss
  • Sickle cell anemia
  • Hemachromatosis
  • Mediterranean anemia
  • Myotonic dystrophy
  • Cardiovascular diseases
  • Ataxia telangectasia
  • Determination of cancer disease in risky families

Some types of cancer are familial in nature, and all individuals in the family are at risk. Diseases that can be studied in terms of predisposition at the embryo level;

  • Alzheimer’s
  • Prostate cancer
  • Leukemia
  • Breast cancer
  • Bladder cancer
  • Ethinoblastoma

At what stage is the Embryo genetically examined?

  • 1st day embryo formation in ‘in vitro fertilization treatment’
  • 3rd day of embryo development
  • 5th day of embryo development



Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)